Our data clearly suggest the existence of VEGFR-2-expressing tumor cells not only in glioma cell lines and GIC but also in patient-derived glioblastoma tissues, preferentially in tumor infiltration zones. The gene discussed is KDR; the disease is central nervous system cancer.